Exosomes derived from MSCs ameliorate retinal laser injury partially by inhibition of MCP-1.
Although accumulated evidence supports the notion that mesenchymal stem cells (MSCs) act in a paracrine manner, the mechanisms are still not fully understood. Recently, MSC-derived exosomes (MSC-Exos), a type of microvesicle released from MSCs, were thought to carry functional proteins and RNAs to recipient cells and play therapeutic roles. In the present study, we intravitreally injected MSCs derived from either mouse adipose tissue or human umbilical cord, and their exosomes to observe and compare their functions in a mouse model of laser-induced retinal injury. We found that both MSCs and their exosomes reduced damage, inhibited apoptosis, and suppressed inflammatory responses to obtain better visual function to nearly the same extent in vivo. Obvious down-regulation of monocyte chemotactic protein (MCP)-1 in the retina was found after MSC-Exos injection. In vitro, MSC-Exos also down-regulated MCP-1 mRNA expression in primarily cultured retinal cells after thermal injury. It was further demonstrated that intravitreal injection of an MCP-1-neutralizing antibody promoted the recovery of retinal laser injury, whereas the therapeutic effect of exosomes was abolished when MSC-Exos and MCP-1 were administrated simultaneously. Collectively, these results suggest that MSC-Exos ameliorate laser-induced retinal injury partially through down-regulation of MCP-1.
Tianjin Medical University Eye Hospital, Eye Institute &School of Optometry and Ophthalmology, Tianjin 300384, China.
Bo
B
Yu
Department of Ophthalmology and Visual Sciences, Kentucky Lions Eye Center, University of Louisville, Louisville, KY, USA.
Hui
H
Shao
Tianjin Medical University Eye Hospital, Eye Institute &School of Optometry and Ophthalmology, Tianjin 300384, China.
Chang
C
Su
Tianjin Medical University Eye Hospital, Eye Institute &School of Optometry and Ophthalmology, Tianjin 300384, China.
Yuanfeng
Y
Jiang
Tianjin Medical University Eye Hospital, Eye Institute &School of Optometry and Ophthalmology, Tianjin 300384, China.
Xiteng
X
Chen
Tianjin Medical University Eye Hospital, Eye Institute &School of Optometry and Ophthalmology, Tianjin 300384, China.
Lingling
L
Bai
Tianjin Medical University Eye Hospital, Eye Institute &School of Optometry and Ophthalmology, Tianjin 300384, China.
Yan
Y
Zhang
Department of Ophthalmology and Visual Sciences, Kentucky Lions Eye Center, University of Louisville, Louisville, KY, USA.
Qiutang
Q
Li
Tianjin Medical University Eye Hospital, Eye Institute &School of Optometry and Ophthalmology, Tianjin 300384, China.
Xiaomin
X
Zhang
Tianjin Medical University Eye Hospital, Eye Institute &School of Optometry and Ophthalmology, Tianjin 300384, China.
Xiaorong
X
Li
Invest Ophthalmol Vis Sci. 2012 Nov 09;53(12):7567-75
23010641
Mol Neurodegener. 2016 Apr 21;11:30
27098079
Exp Eye Res. 2009 Jun 15;89(1):32-41
19268467
Colloids Surf B Biointerfaces. 2011 Oct 1;87(1):146-50
21640565
Stem Cell Res. 2010 May;4(3):214-22
20138817
Immunobiology. 2011 Sep;216(9):1004-9
21531038
Traffic. 2008 Jun;9(6):871-81
18331451
Invest Ophthalmol Vis Sci. 2012 Apr 30;53(4):2368-76
22427549
Stem Cells Dev. 2014 Jun 1;23(11):1233-44
24367916
J Neurosci. 2015 Oct 7;35(40):13568-76
26446211
Regen Med. 2011 Jul;6(4):481-92
21749206
Graefes Arch Clin Exp Ophthalmol. 2009 Mar;247(3):343-8
18987871
Invest Ophthalmol Vis Sci. 2013 Dec 23;54(13):8292-305
24265016
J Mol Neurosci. 2013 Jan;49(1):96-104
23054592
Invest Ophthalmol Vis Sci. 2002 Apr;43(4):1204-9
11923267
Int J Mol Sci. 2014 Mar 07;15(3):4142-57
24608926
Transplant Res. 2013 Jun 20;2(1):10
23786652
Retina. 2012 Jun;32(6):1165-70
22290081
J Leukoc Biol. 1998 Jan;63(1):108-16
9469480
Exp Neurol. 1998 Sep;153(1):1-7
9743562
PLoS One. 2012;7(7):e40065
22802951
Lasers Surg Med. 2006 Aug;38(7):689-94
16868934
Int J Mol Sci. 2014 May 27;15(6):9372-85
24871366
Harefuah. 2015 Feb;154(2):84-8, 138
25856858
Proc Natl Acad Sci U S A. 2007 Feb 13;104(7):2425-30
17284607
Invest Ophthalmol Vis Sci. 2009 Nov;50(11):5472-8
19494207
Invest Ophthalmol Vis Sci. 2005 Aug;46(8):2992-9
16043876
Br J Ophthalmol. 2003 Apr;87(4):488-92
12642316
J Cereb Blood Flow Metab. 2013 Nov;33(11):1711-5
23963371
Invest Ophthalmol Vis Sci. 2014 Aug 14;55(9):5561-71
25125599
Eur J Pharmacol. 2014 Sep 15;739:96-105
24291107
Invest Ophthalmol Vis Sci. 2011 May 16;52(6):3143-52
21296818
Stem Cell Res. 2007 Nov;1(2):129-37
19383393
Front Cell Neurosci. 2014 Nov 10;8:377
25426026
BMC Genomics. 2010 Feb 10;11 Suppl 1:S6
20158877
Invest Ophthalmol Vis Sci. 1997 Jun;38(7):1380-9
9191601
Mol Cell Neurosci. 2013 May;54:1-8
23246669
Biochim Biophys Acta. 2012 Jul;1820(7):940-8
22503788
J Am Soc Nephrol. 2009 May;20(5):927-8
19389839
J Neurol Sci. 2016 Apr 15;363:43-50
27000219
J Immunol. 1989 Mar 15;142(6):1956-62
2921521
J Neuropathol Exp Neurol. 2010 Sep;69(9):973-85
20720501
J Immunol Methods. 2013 Aug 30;394(1-2):22-31
23639298
Stem Cells. 2015 Jul;33(7):2158-68
24964196
EMBO Mol Med. 2013 Nov;5(11):1775-93
24142887
J Neuroinflammation. 2010 Dec 02;7:87
21126357
J Transl Med. 2011 Mar 22;9:29
21418664
Acta Ophthalmol. 2011 Dec;89(8):741-8
20039850
J Neurosci. 2002 Nov 1;22(21):9228-36
12417648
PLoS One. 2012;7(9):e44092
22970165
Exp Eye Res. 2013 Apr;109:67-76
23352833
Stem Cells. 2012 Jul;30(7):1556-64
22605481